Bristol-Myers Squibb Co.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2016
Total Assets: $33.71B
Liabilities Breakdown FY2016
Total Liabilities: $17.36B
Asset Breakdown
Total Assets: $33.71B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.24B | 12.6% |
| Accounts Receivable | $3.77B | 11.2% |
| Inventory | $1.24B | 3.7% |
| Property, Plant & Equipment | $4.98B | 14.8% |
| Goodwill | $6.88B | 20.4% |
| Intangible Assets | $1.39B | 4.1% |
| Other Assets | $11.22B | 33.3% |
Liabilities Breakdown
Total Liabilities: $17.36B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.66B | 9.6% |
| Long-Term Debt | $5.72B | 32.9% |
| Other Liabilities | $9.98B | 57.5% |